Formulation and Evaluation of Cephalexin Extended Release Tablet

CHF 68.75
Auf Lager
SKU
C2QSVTQA5EF
Stock 1 Verfügbar
Geliefert zwischen Mo., 10.11.2025 und Di., 11.11.2025

Details

In this study, controlled release matrix tablets containing cephelexin were prepared using HPMC15 cps and Eudragit L100 in different concentration by Direct compression method. Tablets were evaluated for physical properties,Hardness, friability, weight variation and In vitro dissolution study was carried on USP II apparetus (peddle type). The best formulations selected based on above parameters were subjected for Extend release study with use of different ratio of polymer as Eudragit and HPMC .The tablets with Eudragit were found to release drug for longer duration of time as compared to formulations containing HPMC. The drug release from the tablets was sufficiently sustained.

Autorentext

Mr. Hemendra Kumar Sharma has obtained M. Pharm degree in Pharmaceutical Chemistry in 2011. Since he has published three international and ten national research article in reputed journals in field of analysis and he has also obtained scientific credit from international journal.

Weitere Informationen

  • Allgemeine Informationen
    • Sprache Englisch
    • Autor Hemendra Kumar Sharma , Sandhya Chaurasia , Suneel Kumar Vasireddy
    • Titel Formulation and Evaluation of Cephalexin Extended Release Tablet
    • Veröffentlichung 07.03.2012
    • ISBN 3848432633
    • Format Kartonierter Einband
    • EAN 9783848432639
    • Jahr 2012
    • Größe H220mm x B150mm x T9mm
    • Untertitel Comparatively Study with Marketed Formulations
    • Gewicht 233g
    • Auflage Aufl.
    • Genre Medizin
    • Anzahl Seiten 144
    • Herausgeber LAP LAMBERT Academic Publishing
    • GTIN 09783848432639

Bewertungen

Schreiben Sie eine Bewertung
Nur registrierte Benutzer können Bewertungen schreiben. Bitte loggen Sie sich ein oder erstellen Sie ein Konto.
Made with ♥ in Switzerland | ©2025 Avento by Gametime AG
Gametime AG | Hohlstrasse 216 | 8004 Zürich | Schweiz | UID: CHE-112.967.470